Clinical framework: Non-surgical treatment of infected implant
Link: how to determine if the treatment is non-surgical
Implaprotect Max is only product in the market offering effective treatment of mucositis due to the following characteristics:
Link: how to determine if the treatment is non-surgical
Implaprotect Max is only product in the market offering effective treatment of mucositis due to the following characteristics:
- Highly effective against a broad range of bacteria through antibiotic activity of piperacilline associated with tazobactam avoiding bacterial resistance and increasing local AB activity.
- Hylauraonic acid with high mollecular weight enhances regeneration of hard and soft tissues
- Easy to apply in infected site. After debridement medic will insert the active in 4 segments (north, east, south and west) mimicking parodontal probing.
- When infected sites have been completely filled liquid preparation will appear at gingival border.
- Pharmaco-cynethic activity for a period of 8 days
- No or very limited side effects
- Once opened medical device remains active for 8 weeks for other applications /reinforcements
Product composition
- Powder bottle: Sodium Piperacilline 100 mg, Sodium Tazobactam 12,5 mg
- Solution bottle: Sodium Hyaluronate 0,5%, water for injection on 5 ml
- Three blunt needles and syringes
Product is patented and registered as Medical Device Class III
Treats 8-10 mild peri-implantitis or peri-implant mucositis cases